Modified peptides and organic metabolites of cyanobacterial origin with antiplasmodial properties.

Authors:
Alvarez-Sánchez ME; Arreola R; Quintero-Fabián S; Pérez-Sánchez G.

Journal:
Int J Parasitol Drugs Drug Resist

Publication Year: 2024

DOI:
10.1016/j.ijpddr.2024.100530

PMCID:
PMC10924210

PMID:
38447332

Journal Information

Journal Title: Int J Parasitol Drugs Drug Resist

Detailed journal information not available.

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"additional structures with dolastatin 10 analogs deposited on the pdb and obtained by x-ray diffraction are available (pdb id: 4x1k and 4x20).; additional structures can be downloaded from the pdb database from s cerevisiae 20s proteasome in complex with ek derivatives such as1g65 and 4no9."

Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare no conflict of interest."

Evidence found in paper:

"Funding This work was supported by the 10.13039/501100007487Autonomous University of Mexico City (UACM) awarded to MEAS and the grant of the Colegio de Ciencia y Tecnología for the project UACM CCYT-2023-IMP 03, and to the National Institute of Psychiatry Ramón de la Fuente Muñiz (INPRFM). We appreciate the excellent technical assistance of MsC Laura Vazquez Carrillo and the technical support of Alfredo Padilla of the UACM."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025